Postpartum hyperkalemia associated with magnesium sulfate.
We report the case of a woman who first received MgSO(4) for eclampsia prophylaxis and then was treated with MgSO(4) for eclampsia. She developed hyperkalemia without severe renal failure or another explanation. We recommend close monitoring, including serial measurements of electrolytes, when MgSO(4) is administered for eclampsia prophylaxis or treatment.
Iglesias
Marie-Hélène
MH
Maternal/Fetal Medicine, Department of Obstetrics and Gynaecology, British Columbia Women's Hospital and Health Centre, Vancouver, British Columbia, Canada. iglesiasmh@gmail.com
Giesbrecht
Ellen M
EM
von Dadelszen
Peter
P
Magee
Laura A
LA
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004461:Eclampsia / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008278:Magnesium Sulfate / Q000009:adverse effects*; D049590:Postpartum Period; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011644:Puerperal Disorders / Q000139:chemically induced*; D051437:Renal Insufficiency / Q000139:chemically induced*
D000927:Anticonvulsants; D008278:Magnesium Sulfate